How We Invest
Our funds comprise both private-focused vehicles (Venture Funds) and public-focused vehicles (Public Funds) that enable us to invest across the spectrum of companies developing novel therapeutics. Across all opportunities, we take a collaborative, team-based approach to perform deep technical diligence that leverages the experience of our firm and team.
Venture Funds
Our Venture Funds primarily invest in private companies, focusing on company creation (over 30 companies formed since 2005) and Series A & B companies. We form true partnerships with distinctive entrepreneurs to build world-class companies and accelerate advancement of new therapeutic options for patients. Our latest Venture Fund is Frazier Life Sciences XI, a $987 million fund that was raised in 2022.
Public Funds
Our Public Funds provide capital to small- and mid-cap public biotech companies in financings, including follow-ons including CMPOs, PIPEs, IPOs, as well as supporting our companies in the open market. We partner with our public portfolio companies much as we do with our private portfolio companies. The Public Funds are investing over $1 billion of committed capital.
Our Values
Since 1991, the Frazier Life Sciences team has actively partnered with exceptional entrepreneurs to develop novel and impactful therapies for patients. Underlying these efforts are a set of core values that guide how we invest, advise, and operate as a firm.
![Integrity Icon](https://frazierls.com/wp-content/uploads/2023/07/frazier-values-icons_Integrity.png)
Integrity
We choose the harder right over the easier wrong in serving the interests of patients, portfolio companies, and other stakeholders in the healthcare ecosystem.
![Empowerment Icon](https://frazierls.com/wp-content/uploads/2023/07/frazier-values-icons_Empowerment.png)
Empowerment
We invest in each other (early, often, and thoughtfully) and take ownership in a collaborative, compassionate, and respectful manner to achieve firm goals.
![Perseverance Icon](https://frazierls.com/wp-content/uploads/2023/07/frazier-values-icons_Perseverance.png)
Perseverance
We endeavor to advance patient care with determination and purpose to positively impact our community.
![Transparency Icon](https://frazierls.com/wp-content/uploads/2023/07/frazier-values-icons_Transparency.png)
Transparency
We promote constructively candid and respectful dialogue to get to the right answers.
![Social Impact Icon](https://frazierls.com/wp-content/uploads/2023/07/frazier-values-icons_Social-Impact.png)
Social Impact
We work to effect positive change in the areas of diversity, equity, inclusion, accessibility, and the environment.
![Performance Icon](https://frazierls.com/wp-content/uploads/2023/07/frazier-values-icons_Performance.png)
Performance
We seek to deliver attractive results and improved outcomes for everyone we serve.
Selected Drug Approvals From Our Portfolio
![andexxa logo](https://frazierls.com/wp-content/uploads/2023/07/andexxa-284x160-logo-1.png)
Portola Pharmaceuticals
![bevyxxa logo](https://frazierls.com/wp-content/uploads/2023/07/bevyxxa-284x160-logo-1.png)
Portola Pharmaceuticals
![calquence logo](https://frazierls.com/wp-content/uploads/2023/07/calquence-284x160-logo-1.png)
Acerta Pharma
![epaned logo](https://frazierls.com/wp-content/uploads/2023/07/epaned-284x160-logo-1.png)
Silvergate Pharmaceuticals
![galafold logo](https://frazierls.com/wp-content/uploads/2023/07/galafold-284x160-logo-1.png)
Amicus Therapeutics
![horizant logo](https://frazierls.com/wp-content/uploads/2023/07/horizant-284x160-logo-1.png)
XenoPort
![ionsys logo](https://frazierls.com/wp-content/uploads/2023/07/ionsys-284x160-logo-1.png)
Incline Therapeutics
![jemperli logo](https://frazierls.com/wp-content/uploads/2023/07/jemperli-284x160-logo-1.png)
AnaptysBio
![katerzia logo](https://frazierls.com/wp-content/uploads/2023/07/katerzia-284x160-logo-1.png)
Silvergate Pharmaceuticals
![livmarli logo](https://frazierls.com/wp-content/uploads/2023/07/livmarli-284x160-logo-1.png)
Mirum Pharmaceuticals
![minocin logo](https://frazierls.com/wp-content/uploads/2023/07/minocin-284x160-logo-1.png)
Rempex Pharmaceuticals
![ofirmev logo](https://frazierls.com/wp-content/uploads/2023/07/ofirmev-284x160-logo-1.png)
Cadence Pharmaceuticals
![osphena logo](https://frazierls.com/wp-content/uploads/2023/07/osphena-284x160-logo-1.png)
QuatRx Pharmaceuticals
![pombiliti+Opfolda logo](https://frazierls.com/wp-content/uploads/2023/10/pombiliti-opfolda.jpg)
pombiliti + Opfolda
![qbrelis logo](https://frazierls.com/wp-content/uploads/2023/07/qbrelis-284x160-logo-1.png)
Silvergate Pharmaceuticals
![relizorb logo](https://frazierls.com/wp-content/uploads/2023/07/relizorb-284x160-logo-1.png)
Alcresta Therapeutics
![rezzayo logo](https://frazierls.com/wp-content/uploads/2023/07/rezzayo-284x160-logo-1.png)
Cidara Therapeutics
![rozlytrek logo](https://frazierls.com/wp-content/uploads/2023/07/rozlytrek-284x160-logo-1.png)
Ignyta
![rubraca logo](https://frazierls.com/wp-content/uploads/2023/07/rubraca-284x160-logo-1.png)
Clovis Oncology
![solesta logo](https://frazierls.com/wp-content/uploads/2023/07/solesta-284x160-logo-1.png)
Oceana Therapeutics
![teflaro logo](https://frazierls.com/wp-content/uploads/2023/07/teflaro-284x160-logo-1.png)
Cerexa Pharmaceuticals
![tembexa logo](https://frazierls.com/wp-content/uploads/2023/07/tembexa-284x160-logo-1.png)
Chimerix
![vabomere logo](https://frazierls.com/wp-content/uploads/2023/07/vabomere-284x160-logo-1.png)
Rempex Pharmaceuticals
![Velsipity Logo](https://frazierls.com/wp-content/uploads/2023/10/velsipity-284x160-logo-1.png)
Velsipity
![ventavis logo](https://frazierls.com/wp-content/uploads/2023/07/ventavis-284x160-logo-1.png)
CoTherix
![voquezna dual logo](https://frazierls.com/wp-content/uploads/2023/07/voquezna-dual-284x160-logo-1.png)
Phathom Pharmaceuticals
![voquezna triple logo](https://frazierls.com/wp-content/uploads/2023/07/voquezna-triple-284x160-logo-1.png)
Phathom Pharmaceuticals
![vyjuvek logo](https://frazierls.com/wp-content/uploads/2023/07/vyjuvek-284x160-logo-1.png)
Krystal Biotech
![xacduro logo](https://frazierls.com/wp-content/uploads/2023/07/xacduro-284x160-logo-1.png)
Entasis Therapeutics
![xatmep logo](https://frazierls.com/wp-content/uploads/2023/07/xatmep-284x160-logo-1.png)
Silvergate Pharmaceuticals
![xenleta logo](https://frazierls.com/wp-content/uploads/2023/07/xenleta-284x160-logo-1.png)
Nabriva Therapeutics
![xtampza logo](https://frazierls.com/wp-content/uploads/2023/07/xtampza-284x160-logo-1.png)
Collegium Pharmaceuticals
![zerbaxa logo](https://frazierls.com/wp-content/uploads/2023/07/zerbaxa-284x160-logo-1.png)
Calixa Therapeutics
![zoryve logo](https://frazierls.com/wp-content/uploads/2023/07/zoryve-284x160-logo-1.png)
Arcutis Biotherapeutics
![zydelig logo](https://frazierls.com/wp-content/uploads/2023/07/zydelig-284x160-logo-1.png)
Calistoga Pharmaceuticals
References to specific portfolio companies are presented for illustrative purposes only and should not be considered as being generally representative of all portfolio companies of any particular strategy or fund. For a complete list of all portfolio companies, please see the Portfolio page.